Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125382251 | 12538225 | 1 | I | 20160212 | 20160629 | 20160707 | 20160707 | EXP | FR-ASTRAZENECA-2016SE72371 | ASTRAZENECA | 28250.00 | DY | M | Y | 0.00000 | 20160707 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125382251 | 12538225 | 1 | PS | BRILIQUE | TICAGRELOR | 1 | Oral | Y | U | 22433 | 90 | MG | TABLET | QD | |||||
125382251 | 12538225 | 2 | SS | BRILIQUE | TICAGRELOR | 1 | Oral | Y | U | 22433 | 90 | MG | TABLET | QD | |||||
125382251 | 12538225 | 3 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | Y | U | 0 | |||||||||
125382251 | 12538225 | 4 | SS | SODIUM PIPERACILLIN | PIPERACILLIN SODIUM | 1 | Intravenous (not otherwise specified) | Y | U | 0 | |||||||||
125382251 | 12538225 | 5 | SS | SODIUM TAZOBACTAM | TAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | Y | U | 0 | |||||||||
125382251 | 12538225 | 6 | SS | AMIODARONE | AMIODARONE | 1 | Unknown | 5800 | MG | Y | U | 0 | 200 | MG | QD | ||||
125382251 | 12538225 | 7 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 116000 | IU | Y | U | 0 | 4000 | IU | QD | ||||
125382251 | 12538225 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
125382251 | 12538225 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
125382251 | 12538225 | 10 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 | ||||||||||||
125382251 | 12538225 | 11 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | 75 | MG | QD | |||||||||
125382251 | 12538225 | 12 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | 75 | MG | QD | |||||||||
125382251 | 12538225 | 13 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 0 | 3.75 | G | QD | ||||||||
125382251 | 12538225 | 14 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Oral | 0 | 10 | G | QD | ||||||||
125382251 | 12538225 | 15 | C | IMOVANE | ZOPICLONE | 1 | Oral | 0 | 3.75 | MG | QD | ||||||||
125382251 | 12538225 | 16 | C | INEXIUM | ESOMEPRAZOLE | 1 | 0 | 20 | MG | QD | |||||||||
125382251 | 12538225 | 17 | C | TADENAN | PYGEUM | 1 | Intravenous (not otherwise specified) | 0 | 50 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125382251 | 12538225 | 1 | Myocardial ischaemia |
125382251 | 12538225 | 2 | Myocardial ischaemia |
125382251 | 12538225 | 3 | Oesophagitis |
125382251 | 12538225 | 4 | Lung disorder |
125382251 | 12538225 | 5 | Lung disorder |
125382251 | 12538225 | 6 | Arrhythmia |
125382251 | 12538225 | 7 | Thrombosis prophylaxis |
125382251 | 12538225 | 10 | Sepsis |
125382251 | 12538225 | 11 | Myocardial ischaemia |
125382251 | 12538225 | 12 | Myocardial ischaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125382251 | 12538225 | HO |
125382251 | 12538225 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125382251 | 12538225 | Agitation | |
125382251 | 12538225 | Enterobacter test positive | |
125382251 | 12538225 | Escherichia test positive | |
125382251 | 12538225 | Immune thrombocytopenic purpura | |
125382251 | 12538225 | Lung disorder | |
125382251 | 12538225 | Off label use | |
125382251 | 12538225 | Oxygen saturation decreased | |
125382251 | 12538225 | Respiratory tract haemorrhage | |
125382251 | 12538225 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125382251 | 12538225 | 1 | 20160115 | 20160127 | 0 | |
125382251 | 12538225 | 2 | 20160211 | 20160212 | 0 | |
125382251 | 12538225 | 3 | 20160115 | 20160212 | 0 | |
125382251 | 12538225 | 4 | 20160125 | 20160212 | 0 | |
125382251 | 12538225 | 5 | 20160125 | 20160212 | 0 | |
125382251 | 12538225 | 6 | 20160115 | 201602 | 0 | |
125382251 | 12538225 | 7 | 20160115 | 20160212 | 0 | |
125382251 | 12538225 | 10 | 20160116 | 20160125 | 0 | |
125382251 | 12538225 | 11 | 20160128 | 20160210 | 0 | |
125382251 | 12538225 | 12 | 20160215 | 0 | ||
125382251 | 12538225 | 13 | 20160115 | 0 | ||
125382251 | 12538225 | 16 | 20160115 | 0 | ||
125382251 | 12538225 | 17 | 20160115 | 0 |